利爾化學(002258.SZ):控股股東所持750.1272萬股將變更登記至社保基金會所持股票賬户
格隆匯 3 月 16日丨利爾化學(002258.SZ)公佈,公司近日收到公司實際控制人中國工程物理研究院(“中物院”)轉發的國家財政部文件,主要內容如下:
根據《財政部人力資源社會保障部國資委税務總局證監會關於全面推開劃轉部分國有資本充實社保基金工作的通知》(財資[2019]49號)有關規定,應將公司控股股東四川久遠投資控股集團有限公司(“久遠集團”)所持公司750.1272萬股無限售流通股從久遠集團開設的股票賬户變更登記至社保基金會所持股票賬户。
此次無償劃轉完成前,久遠集團持有公司27.36%股權,為公司控股股東;中物院間接持有公司36.54%股權,為公司實際控制人。
此次無償劃轉完成後,久遠集團持有公司25.93%股權,仍為公司控股股東;中物院間接持有公司35.11%股權,仍為公司實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.